Cleveland Clinic has launched a partnership with bioanalytics company Aspira Women’s Health to advance diagnostics through AI.
The organizations aim to accelerate the development and future commercialization of multiomic diagnostics across women’s health, according to a May 26 news release from Cleveland Clinic.
The partnership will be led by Kevin Elias, MD, the Lilli and Seth Harris Endowed Chair for Ovarian Cancer Research at Cleveland Clinic, alongside Todd Pappas, PhD, chief scientific officer at Aspira Women’s Health.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
